Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (481-490 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|June 10, 2017
Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risksKristell Lebozec, Martine Jandrot-Perrus, Gilles Avenard, et al.
Mabs|September 10, 2016
Precise quantification of mixtures of bispecific IgG produced in single host cells by liquid chromatography-Orbitrap high-resolution mass spectrometryYiyuan Yin, Guanghui Han, Jianhui Zhou, et al.
Mabs|February 8, 2022
BioPhi: A platform for antibody design, humanization, and humanness evaluation based on natural antibody repertoires and deep learningDavid Prihoda, Jad Maamary, Andrew Waight, et al.
Mabs|February 8, 2024
Correction
Mabs|January 29, 2022
Structural and functional characterization of a monoclonal antibody blocking TIGITBo-Seong Jeong, Hyemi Nam, Jeewon Lee, et al.
Mabs|November 1, 2021
Preclinical characterization of bemarituzumab, an anti-FGFR2b antibody for the treatment of cancerHong Xiang, Abigael G Chan, Ago Ahene, et al.
Mabs|October 1, 2021
Antibody blockade of CD96 by distinct molecular mechanismsPeter S Lee, Bryant Chau, Ishita Barman, et al.
Mabs|March 11, 2022
In silico high throughput mutagenesis and screening of signal peptides to mitigate N-terminal heterogeneity of recombinant monoclonal antibodiesXin Yu, Merlinda Conyne, Marc R Lake, et al.
Mabs|June 15, 2019
Site-specific antibody-drug conjugate heterogeneity characterization and heterogeneity root cause analysisMingyan Cao, Niluka De Mel, Yang Jiao, et al.
Mabs|December 13, 2023
Determining the affinities of high-affinity antibodies using KinExA and surface plasmon resonanceM Frank Erasmus, Molly Dovner, Fortunato Ferrara, et al.
Pageof 184

Showing results (481-490 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|June 10, 2017
Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risksKristell Lebozec, Martine Jandrot-Perrus, Gilles Avenard, et al.
Mabs|September 10, 2016
Precise quantification of mixtures of bispecific IgG produced in single host cells by liquid chromatography-Orbitrap high-resolution mass spectrometryYiyuan Yin, Guanghui Han, Jianhui Zhou, et al.
Mabs|February 8, 2022
BioPhi: A platform for antibody design, humanization, and humanness evaluation based on natural antibody repertoires and deep learningDavid Prihoda, Jad Maamary, Andrew Waight, et al.
Mabs|February 8, 2024
Correction
Mabs|January 29, 2022
Structural and functional characterization of a monoclonal antibody blocking TIGITBo-Seong Jeong, Hyemi Nam, Jeewon Lee, et al.
Mabs|November 1, 2021
Preclinical characterization of bemarituzumab, an anti-FGFR2b antibody for the treatment of cancerHong Xiang, Abigael G Chan, Ago Ahene, et al.
Mabs|October 1, 2021
Antibody blockade of CD96 by distinct molecular mechanismsPeter S Lee, Bryant Chau, Ishita Barman, et al.
Mabs|March 11, 2022
In silico high throughput mutagenesis and screening of signal peptides to mitigate N-terminal heterogeneity of recombinant monoclonal antibodiesXin Yu, Merlinda Conyne, Marc R Lake, et al.
Mabs|June 15, 2019
Site-specific antibody-drug conjugate heterogeneity characterization and heterogeneity root cause analysisMingyan Cao, Niluka De Mel, Yang Jiao, et al.
Mabs|December 13, 2023
Determining the affinities of high-affinity antibodies using KinExA and surface plasmon resonanceM Frank Erasmus, Molly Dovner, Fortunato Ferrara, et al.
Pageof 184